default simcyp-plugin parameter estimation (pe) module (Simcyp)
90
Structured Review
Simcyp
default simcyp-plugin parameter estimation (pe) module
Default Simcyp Plugin Parameter Estimation (Pe) Module, supplied by Simcyp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/parameter+estimation+module/parameter+estimation+module+using+simcyp+program/pmc10955231-88-13-9
Average 90 stars, based on 1 article reviews
Default Simcyp Plugin Parameter Estimation (Pe) Module, supplied by Simcyp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/parameter+estimation+module/parameter+estimation+module+using+simcyp+program/pmc10955231-88-13-9
Average 90 stars, based on 1 article reviews
default simcyp-plugin parameter estimation (pe) module - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
other:Article Title: Assessing the relative contribution of CYP3A-and P-gp-mediated pathways to the overall disposition and drug-drug interaction of dabigatran etexilate using a comprehensive mechanistic physiological-based pharmacokinetic model Article Snippet: A top-down estimation was carried out via a Article Title: Evaluation of Maternal Drug Exposure Following the Administration of Antenatal Corticosteroids During Late Pregnancy Using Physiologically-Based Pharmacokinetic Modeling. Article Snippet: Betamethasone and dexamethasone are the most widely studied antenatal corticosteroids (ACS) administered to pregnant women, just prior to the birth of a pre-term neonate, to accelerate fetal lung maturation.. Although betamethasone, predominantly used in developed countries, has been shown to be an effective and safe intervention for reducing neonatal mortality, the choice of ACS and optimal dosing in low middle income countries (LMICs) remains unclear.. This is primarily A cc ep te d A rt ic le This article is protected by copyright. Article Title: A Physiologically Based Pharmacokinetic Model for Optimally Profiling Lamotrigine Disposition and Drug-Drug Interactions. Article Snippet: Background and Objectives Lamotrigine (Lamictal®) is a broad-spectrum antiepileptic drug available in both immediate(IR) and extended-release (XR) formulations.. Here, we present a new physiologically based pharmacokinetic (PBPK) model for IR and XR formulations of lamotrigine to predict disposition in adults and children, plus drug–drug interactions (DDIs).. Methods Models for lamotrigine IR and XR formulations were constructed using a Simcyp® Simulator. Article Title: A physiologically based pharmacokinetic modelling approach to predict buprenorphine pharmacokinetics following intravenous and sublingual administration Article Snippet: The E:P is estimated using the Article Title: Establishing virtual bioequivalence and clinically relevant specifications using in vitro biorelevant dissolution testing and physiologically-based population pharmacokinetic modeling. case example: Naproxen. Article Snippet: Use of the SAC requires prior fitting to observed clinical data using the Permeability:Article Title: Comparative assessment of saliva and plasma for drug bioavailability and bioequivalence studies in humans Article Snippet: The following dimensionless ratios were calculated: AUC t ∗ = saliva AUC t /plasma AUC t T max ∗ = saliva T max /plasma T max C max ∗ = saliva C max /plasma C max C ∗ = saliva Concentration/plasma concentration = C s / C p P eff ∗ = dimensionless effective permeability = ( R · P eff )/ D where D is drug diffusivity as predicted by SimCYP. .. Effective intestinal permeability ( P eff ) values were estimated by Nelder-Mead algorithm of Article Title: A physiologically-based pharmacokinetic model adequately predicted the human pharmacokinetic profiles of YH4808, a novel K + -competitive acid blocker. Article Snippet: Accepted Manuscript A physiologically-based pharmacokinetic model adequately predicted the human pharmacokinetic profiles of YH4808, a novel K+-competitive acid blocker Hyun A. Lee, Kyeong-Ryoon Lee, Seong Bok Jang, Soo Young Chung, Kyung-Sang Yu, Howard Lee PII: S0928-0987(19)30017-X DOI: https://doi.org/10.1016/j.ejps.2019.01.009 Reference: PHASCI 4800 To appear in: European Journal of Pharmaceutical Sciences Received date: 8 August 2018 Revised date: 13 December 2018 Accepted date: 9 January 2019 Please cite this article as: Hyun A. Lee, Kyeong-Ryoon Lee, Seong Bok Jang, Soo Young Chung, Kyung-Sang Yu, Howard Lee , A physiologically-based pharmacokinetic model adequately predicted the human pharmacokinetic profiles of YH4808, a novel K+competitive acid blocker.. Phasci (2019), https://doi.org/10.1016/j.ejps.2019.01.009 This is a PDF file of an unedited manuscript that has been accepted for publication.. As a service to our customers we are providing this early version of the manuscript. Concentration Assay:Article Title: A physiologically-based pharmacokinetic model adequately predicted the human pharmacokinetic profiles of YH4808, a novel K + -competitive acid blocker. Article Snippet: Accepted Manuscript A physiologically-based pharmacokinetic model adequately predicted the human pharmacokinetic profiles of YH4808, a novel K+-competitive acid blocker Hyun A. Lee, Kyeong-Ryoon Lee, Seong Bok Jang, Soo Young Chung, Kyung-Sang Yu, Howard Lee PII: S0928-0987(19)30017-X DOI: https://doi.org/10.1016/j.ejps.2019.01.009 Reference: PHASCI 4800 To appear in: European Journal of Pharmaceutical Sciences Received date: 8 August 2018 Revised date: 13 December 2018 Accepted date: 9 January 2019 Please cite this article as: Hyun A. Lee, Kyeong-Ryoon Lee, Seong Bok Jang, Soo Young Chung, Kyung-Sang Yu, Howard Lee , A physiologically-based pharmacokinetic model adequately predicted the human pharmacokinetic profiles of YH4808, a novel K+competitive acid blocker.. Phasci (2019), https://doi.org/10.1016/j.ejps.2019.01.009 This is a PDF file of an unedited manuscript that has been accepted for publication.. As a service to our customers we are providing this early version of the manuscript. |